Argo Translation, Inc. Exhibiting at American Medical Writers Associations Annual Conference

Chicago, IL (Vocus) November 8, 2010

Argo Translation, Inc. is proud to announce that they will be exhibiting at the American Medical Writers Associations Annual Conference, held in Milwaukee. This years conference will be held November 10th through the 13th at the Hilton Milwaukee Civic Center.

Argo Translations booth will be manned by Operations Manager and CEO, Peter Argondizzo as well as Marketing Coordinator, Caitlin Harte. They will be offering free demos and giveaways. The Argo Translation booth will offer visitors the opportunity to win a new Amazon Wi-Fi Kindle, as well as a copy of MadCap Flare. Flare is a powerful, XML-based professional content authoring and publishing software application that will allow medical writers to create and manage content for multiple channel publishing. The booth will feature a fish-bowl business card drawing for these two products. Argo Translation and MadCap Software invite all attendees to stop by for an introduction as well as the chance to win prizes.

Both Argondizzo and Harte are excited for the opportunity to meet with a new group of medical writers. Argondizzo says, We have handled many projects for medical device manuafacturers and healthcare providers over the last 15 years so I am excited to exhibit at our first AMWA Conference. Argondizzo continues, We currently work with a number of medical device companies as well as technical writers. Our current clients have seen the benefits of using a trusted translation agency for their foreign language and compliance needs. We are excited to show what our company can offer to this group of writers.

To learn more about Argo Translation, Inc please visit http://www.argotrans.com. If you are interested in attending the AMWA Annual Conference this year in Milwaukee please visit http://www.amwa.org

About ARGO Translation

Having successfully executed projects requiring simultaneous translations in 46 different languages, ARGO Translation provides specialized and professional translation services for a multitude of domains ranging from legal and technical to marketing and financial and everything in between. Argo provides efficient, accurate translation and localization services focused on quality and clarity for a wide range of companies across North America. More information is available at http://www.argotrans.com.

###

Related Org Domains Press Releases

Hayes Executive Joins International Whos Who of Medical Professionals in Highlighting Inconsistencies in Genetic Testing

Lansdale, PA (PRWEB) November 10, 2010

Hayes, Inc., an independent health technology research and consulting company dedicated to promoting better health outcomes, today announced that Dr. Diane Allingham-Hawkins, Director of its Genetic Test Evaluation Program, is a member of a team of international thought leaders that published an authoritative textbook on issues in genetic testing.

The textbook, published earlier this year by Springer Science+Business Media, is entitled Quality Issues in Clinical Genetic Services and includes contributions from an international field of medical professionals from countries such as Australia, Belgium, Canada, England, France, Ireland, Portugal, and the United States.

Dr. Allingham-Hawkins, in collaboration with Dr. Martin Somerville, contributed a chapter titled Regulation of Genetic Testing/Service in Canada. Dr. Somerville practices and teaches Medical Genetics and Pediatrics at the University of Alberta in Edmonton and is the current President of the Canadian College of Medical Geneticists (CCMG).

The chapter explores inconsistencies in the regulation of genetic testing in Canada, a problem that is exacerbated by issues such as the wide range of responsibilities for health services among federal and provincial/territorial ministries of health; the lack of overarching regulations or guidelines for quality assurance or delivery of genetic testing services throughout Canada; and varying levels of regulation in each Canadian jurisdiction. Drs. Allingham-Hawkins and Somerville recommend additional nationwide guidelines to ensure uniform minimum standards for quality and patient/consumer protection.

Dr. Allingham-Hawkins states, Since the advent of genetic testing more than 20 years ago, healthcare professionals, payers, and government entities have struggled with how the information from these tests can be applied in a clinical setting to improve patient care. Unfortunately this problem persists today, resulting in limited acceptance of genetic testing in the healthcare arena. Quality Issues in Clinical Genetic Services highlights these continuing issues, and hopefully will serve as a catalyst for action around the world.

Dr. Allingham-Hawkins went on to say, Challenges with genetic testing are similar in the United States to those in Canada, but they are exacerbated by aggressive direct-to-consumer advertising by test developers. This creates demand for tests that in many cases have uncertain clinical utility and puts pressure on payers to fund this demand.

Dr. Winifred Hayes, President and Chief Executive Officer of Hayes adds, Hayes launched its Genetic Test Evaluation Program in 2008 under the leadership of Dr. Diane Allingham-Hawkins, and we are proud of her accomplishments as an international expert on issues in genetic testing. Her contribution to this seminal book on genetic testing validates her role as a healthcare industry thought leader and person of action.

The book was conceptualized during a meeting at the Organisation for Economic Co-operation and Development (OECD), when several of the chapter contributors participated in the development of international guidelines for quality assurance in molecular genetic testing. Quality Issues in Clinical Genetic Services is available on the Springer website. Additional information on the Hayes Genetic Test Evaluation Service can be found at http://www.hayesinc.com.

Hayes, Inc. is an independent health technology research and consulting company dedicated to promoting better health outcomes through the use of evidence. The Hayes Genetic Test Evaluation (GTE) program cuts through the genohype to the scientific proof regarding the appropriate use of genetic and genomic tests in clinical practice. Currently, there are more than 2000 genetic and genomic tests for inherited and acquired disorders on the market in the United States. With an annual growth rate of 25%, this rapidly growing field has created challenges for healthcare professionals to respond quickly and appropriately to issues related to these tests. Hayes GTE conducts evidence-based assessments with clear, concise conclusions across a range of conditions and applications, including hereditary, cardiovascular, neurological, and developmental disorders, as well as oncology. http://www.hayesinc.com

###